Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Esketamine Combined With Propofol for Sedation on Systemic Inflammation and Immune Function in Septic Patients in the ICU
NCT04843982Phase 4Terminated
- Start
- Jul 2021
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in sepsis. Started Jul 2021; status: terminated.
02
Drugs
esketamine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04843982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843982.